Embecta Corp. (EMBC)
Embecta Corp. is a medical technology enterprise devoted to enhancing the quality of life and health outcomes for individuals living with diabetes. Its comprehensive product portfolio includes essential tools such as pen needles, syringes, and advanced safety devices. Additionally, the company provides innovative digital applications designed to support patients in effectively managing their condition. Embecta distributes its offerings primarily through a network of wholesalers and distributors, reaching markets both domestically within the United States and across the globe. Established in 1924, Embecta's headquarters are located in Parsippany, New Jersey. The company transitioned to an independent entity from Becton, Dickinson and Company on April 1, 2022.
Sector: Surgical & Medical Instruments & Apparatus
Industry: Medical - Instruments & Supplies
Embecta Corp.
NASDAQ:EMBCHealthcare · Drug Manufacturers - Specialty & Generic
PrePre-market+1.62%$6.29
Close$6.190.00%AH$6.19+1.62%Now$6.29
Close$6.19-2.21%AH$6.19+1.62%since
Mkt Cap$350.72M
Float55.96M
O/S56.66M
Inst Own90.4%
SI10.5%
Div Yield5.17%
Dilution
Financials Summary
Revenue$1.08B
Net Income$95.4M
Total Assets$1.09B
Free Cash Flow$182.4M
Debt & Equity
Debt 184%
Total Debt$1.43B
Total Equity-$651.2M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in EMBC's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$1.09B
Liabilities$1.74B
Accounts Receivable$148.9M
Accounts Payable$74.2M
Inventory$178.6M
PP&E (Net)$257.2M
Goodwill$15.4M
Intangible Assets$7M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
| Revenue | $1.08B | $1.12B | $1.12B | $1.13B | $1.17B | $1.09B | $1.11B |
| YoY Growth | -3.8% | 0.2% | -0.8% | -3.0% | 7.3% | -2.1% | - |
| Cost of Revenue | $400.9M | $394.2M | $370.9M | $354.6M | $365M | $323M | $323M |
| Gross Profit | $679.5M | $728.9M | $749.9M | $774.9M | $800M | $763M | $786M |
| Gross Margin | 62.9% | 64.9% | 66.9% | 68.6% | 68.7% | 70.3% | 70.9% |
| Research and Development | $21.5M | $78.8M | $85.2M | $65M | $63M | $61M | $62M |
| Selling, General, and Administrative | $331.4M | $365.1M | $341.3M | $294.8M | $240.3M | $214.7M | $222M |
| Other | -$2.7M | $110.8M | $93.8M | $37M | $5M | $0 | $0 |
| Total Operating Expenses | $350.2M | $554.7M | $520.3M | $396.8M | $308M | $276M | $284M |
| Operating Income (EBIT) | $329.3M | $174.2M | $229.6M | $378.1M | $492M | $487M | $502M |
| Operating Margin | 30.5% | 15.5% | 20.5% | 33.5% | 42.2% | 44.9% | 45.3% |
| Interest Expense | $107.3M | $112.3M | $107M | $46.2M | $0 | $0 | $0 |
| Interest Income | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Income (Expense) | -$193M | -$130M | -$123.9M | -$121.5M | $3M | -$1M | -$2M |
| Income Before Tax (EBT) | $136.3M | $44.2M | $105.7M | $256.6M | $495M | $485.8M | $500M |
| Income Tax Expense | $40.9M | -$34.1M | $35.3M | $33M | $80M | $58.2M | $68M |
| Net Income | $95.4M | $78.3M | $70.4M | $223.6M | $414.8M | $427.6M | $432M |
| Net Income Margin | 8.8% | 7.0% | 6.3% | 19.8% | 35.6% | 39.4% | 39.0% |
| Supplementary Data | |||||||
| EPS | 1.64 | 1.34 | 1.23 | 3.92 | 7.31 | 7.50 | 7.58 |
| Diluted EPS | 1.62 | 1.34 | 1.22 | 3.89 | 7.31 | 7.50 | 7.58 |
| Weighted Average OS | 58.31M | 58.33M | 57.24M | 57.06M | 56.80M | 57.00M | 57.00M |
| EBITDA | $284.3M | $192.7M | $245.3M | $334.5M | $533M | $524.3M | $536M |
| EBITDA Margin | 26.3% | 17.2% | 21.9% | 29.6% | 45.8% | 48.3% | 48.3% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
| Assets | |||||||
| Current Assets | |||||||
| Cash and Cash Equivalents | $225.5M | $267.5M | $326.3M | $330.9M | $0 | $0 | $0 |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $225.5M | $267.5M | $326.5M | $330.9M | $0 | $0 | $0 |
| Accounts Receivable | $148.9M | $248M | $17.9M | $23.4M | $150.6M | $120M | $127M |
| Inventory | $178.6M | $171.5M | $152.1M | $122.8M | $118M | $102M | $101M |
| Other Current Assets | $78.4M | $74M | $142.4M | $109.7M | $200K | $0 | $0 |
| Total Current Assets | $631.4M | $761M | $749.1M | $664.7M | $292M | $235M | $248M |
| Long-Term Assets | |||||||
| Property, Plant & Equipment Net | $257.2M | $290.4M | $323.2M | $301.6M | $451M | $462M | $457M |
| Goodwill | $15.4M | $15.6M | $15.6M | $15.7M | $16M | $16M | $16M |
| Intangible Assets | $7M | $8.1M | $9.1M | $8.9M | $18M | $14M | $16M |
| Long-Term Investments | $0 | $0 | $0 | -$95.5M | -$11.4M | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $95.5M | $11.4M | $0 | $0 |
| Other Long-Term Assets | $179.9M | $210.2M | $117.4M | $95.5M | $11M | $11M | $8M |
| Total Long-Term Assets | $459.5M | $524.3M | $465.3M | $421.7M | $496M | $503M | $497M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $1.09B | $1.29B | $1.21B | $1.09B | $788M | $738M | $745M |
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts Payable | $74.2M | $91M | $53.5M | $41.4M | $54.2M | $50M | $47M |
| Short-Term Debt | $9.5M | $9.5M | $9.5M | $9.5M | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $26.7M | $33.6M | $27.2M | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $33.6M | $0 | $0 | -$1M | $0 |
| Other Current Liabilities | $0 | $0 | $33.6M | $0 | $0 | $1M | $0 |
| Total Current Liabilities | $261.5M | $374M | $353.5M | $301M | $164M | $137M | $126M |
| Long-Term Liabilities | |||||||
| Long-Term Debt | $1.39B | $1.57B | $1.59B | $1.6B | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | -$46.1M | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $11.9M | $0 | $46.1M | $0 | $29M | $0 |
| Other Long-Term Liabilities | $63.2M | $42.2M | $57.2M | $41.8M | $26.7M | $0 | $0 |
| Total Long-Term Liabilities | $1.48B | $1.65B | $1.68B | $1.68B | $29.7M | $29M | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $1.74B | $2.02B | $2.04B | $1.98B | $194M | $166M | $126M |
| Stockholders' Equity | |||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $600K | $600K | $600K | $865M | $834M | $855M |
| Retained Earnings | -$445.6M | -$498.6M | -$541.1M | -$577.1M | $0 | $0 | $0 |
| Comprehensive Income & Other | -$285.6M | -$292.8M | -$309.1M | -$324.9M | -$271M | -$262M | -$278M |
| Other Stockholders' Equity | -$205.6M | -$240.3M | -$281.2M | -$314.9M | -$271M | -$262M | -$278M |
| Total Equity | -$651.2M | -$738.3M | -$821.7M | -$891.4M | $594M | $572M | $577M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $1.09B | $1.29B | $1.21B | $1.09B | $788M | $738M | $703M |
| Supplementary Data | |||||||
| Total Debt | $1.43B | $1.61B | $1.64B | $1.64B | $4.1M | $0 | $0 |
| Net Debt | $1.2B | $1.34B | $1.31B | $1.31B | $4.1M | $0 | $0 |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
| Operating Activities | |||||||
| Net Income | $95.4M | $78.3M | $70.4M | $223.6M | $415M | $427.6M | $432M |
| Depreciation & Amortization | $40.7M | $36.2M | $32.6M | $31.7M | $38M | $38.3M | $36M |
| Deferred Income Tax | $17.6M | -$70.6M | $14.3M | -$26.5M | -$2M | -$2.2M | -$6M |
| Stock-Based Compensation | $31.6M | $26.3M | $21.5M | $18.7M | $12.8M | $12.7M | $12M |
| Changes in Working Capital: | |||||||
| Accounts Receivable | $44.2M | -$174.7M | $7M | $122.7M | -$32M | -$2.4M | -$10M |
| Inventory | -$6.1M | -$16.5M | -$28.8M | -$23.4M | -$18M | $3.5M | $9M |
| Accounts Payable | -$68.9M | $60M | $7.9M | $73.3M | $30M | -$3.8M | $32M |
| Other Working Capital | $7.1M | $83.5M | -$66.1M | -$80.2M | -$12M | $15.4M | -$9M |
| Total Working Capital Change | -$23.7M | -$47.7M | -$80M | $92.4M | -$32M | $12.7M | $22M |
| Other Non-Cash Items | $30.1M | $13.2M | $8.9M | $72.3M | $24.2M | $9.4M | $9M |
| Net Cash from Operating | $191.7M | $35.7M | $67.7M | $412.2M | $456M | $498.5M | $505M |
| Investing Activities | |||||||
| Capital Expenditures | -$9.3M | -$15.8M | -$26.5M | -$24M | -$39M | -$41.9M | -$69M |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Investing | -$9.3M | -$15.8M | -$26.5M | -$24M | -$39M | -$41.9M | -$69M |
| Financing Activities | |||||||
| Debt Repaid | $186M | $35.9M | $10.7M | -$1.44B | - | - | - |
| Common Stock Issuance | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock Repurchases | -$5.7M | -$3M | -$3.6M | $0 | $0 | $0 | $0 |
| Dividends Paid | -$35M | -$34.5M | -$34.4M | -$8.6M | $0 | $0 | $0 |
| Other Financing Activities | $0 | $0 | $0 | -$1.48B | -$417M | -$456.6M | -$436M |
| Net Cash from Financing | -$226.7M | -$73.4M | -$48.7M | -$48M | -$417M | -$456.6M | -$436M |
| Forex Effect | -$1.3M | $1.2M | $3.1M | -$9.3M | $0 | $0 | $0 |
| Net Change in Cash | -$45.6M | -$52.3M | -$4.4M | $330.9M | $0 | $0 | $0 |
| Supplementary Data | |||||||
| Operating Cash Flow | $191.7M | $35.7M | $67.7M | $412.2M | $456M | $498.5M | $505M |
| Capital Expenditure | -$9.3M | -$15.8M | -$26.5M | -$24M | -$39M | -$41.9M | -$69M |
| Free Cash Flow | $182.4M | $19.9M | $41.2M | $388.2M | $417M | $456.6M | $436M |
| Cash at Beginning | $274.2M | $326.5M | $330.9M | $0 | $0 | $0 | $0 |
| Cash at End | $228.6M | $274.2M | $326.5M | $330.9M | $0 | $0 | $0 |